# Efficacy of Glucagon In the Prevention of Hypoglycemia During Mild Exercise

> **NCT03217175** · NA · TERMINATED · sponsor: **Massachusetts General Hospital** · enrollment: 22 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DEVICE:** Bihormonal Bionic Pancreas
- **DEVICE:** Insulin Only Bionic Pancreas
- **DRUG:** Glucagon
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03217175
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-08-18
- **Primary completion:** 2018-03-09
- **Final completion:** 2018-03-09
- **Target enrollment:** 22 (ACTUAL)
- **Why stopped:** Lack of appropriate funds
- **Last updated:** 2019-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03217175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03217175, "Efficacy of Glucagon In the Prevention of Hypoglycemia During Mild Exercise". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03217175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*